Search

Your search keyword '"Juntas-Morales, Raul"' showing total 212 results

Search Constraints

Start Over You searched for: Author "Juntas-Morales, Raul" Remove constraint Author: "Juntas-Morales, Raul"
212 results on '"Juntas-Morales, Raul"'

Search Results

1. FHL1 is a key player of chikungunya virus tropism and pathogenesis

3. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

4. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

5. Functional and Molecular Characterization of New SPTLC1 Missense Variants in Patients with Hereditary Sensory and Autonomic Neuropathy Type 1 (HSAN1)

6. The Hexokinase 1 5′-UTR Mutation in Charcot–Marie–Tooth 4G Disease Alters Hexokinase 1 Binding to Voltage-Dependent Anion Channel-1 and Leads to Dysfunctional Mitochondrial Calcium Buffering

7. Gait Assessment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

8. Convergence of patient- and physician-reported outcomes in the French National Registry of Facioscapulohumeral Dystrophy

9. Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.

10. Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera

11. Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins

13. HeterozygousSPTLC1p.Leu39del is a major cause of slow-progressing juvenile ALS

14. FHL1 is a major host factor for chikungunya virus infection

15. LRSAM1 variants and founder effect in French families with ataxic form of Charcot-Marie-Tooth type 2

17. Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy

18. Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centres

19. Heterozygous SPTLC1 p.Leu39del is a major cause of slow- progressing juvenile ALS.

20. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

21. Subgroup outcomes from RAISE: A randomized, Phase 3 trial of zilucoplan in generalized myasthenia gravis (P1-5.006)

23. Diagnosis and management of Becker muscular dystrophy: the French guidelines.

24. Titin copy number variations associated with dominant inherited phenotypes

26. Immunological, Clinical, and Epidemiological Features of Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection

27. Limb-girdle myopathy and mild intellectual disability: the expanding spectrum of TANGO2-related disease

28. Distal hereditary motor neuropathy due to a novelYARS1gene pathogenic variant

29. Chronic progressive external ophthalmoplegia plus syndrome due to homozygous missense variant in TOP3A gene

30. Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies

33. RFC1 nonsense and frameshift variants cause CANVAS: clues for an unsolved pathophysiology

35. Identification of two novel RRM2Bvariants associated with autosomal recessive progressive external ophthalmoplegia in a family with pseudodominant inheritance pattern

37. Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy

39. Charcot-Marie-Tooth disease type 2CC due to NEFH variants causes a progressive, non-length-dependent, motor-predominant phenotype

40. An Integrated Clinical-Biological Approach to Identify Interindividual Variability and Atypical Phenotype-Genotype Correlations in Myopathies: Experience on A Cohort of 156 Families

41. Novel dominant distal titinopathy phenotype associated with copy number variation

42. Genotype–phenotype correlation in French patients with myelin protein zero gene‐related inherited neuropathy

44. Chronic progressive external ophthalmoplegia plus syndrome due to homozygous missense variant in TOP3A gene.

45. Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal".

46. Expanding the Spectrum ofAP5Z1‐Related Hereditary Spastic Paraplegia ( HSP‐SPG48 ): A Multicenter Study on a Rare Disease

47. Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2

48. The importance of an integrated genotype-phenotype strategy to unravel the molecular bases of titinopathies

49. Clinical phenotype and loss of the slow skeletal muscle troponin T in three new patients with recessive TNNT1 nemaline myopathy

50. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial

Catalog

Books, media, physical & digital resources